Strides arm and its partner get USFDA nod for hypokalemia treatment drug

The approved product, used in treatment of patients with hypokalemia, is a generic version of Merck, Inc's Potassium Chloride extended-release tablets, a regulatory filing said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2VaQgo4
via IFTTT